Breast Cancer Clinical Trial
Official title:
DAMES: Daughters And MothErS Against Breast Cancer
| Verified date | July 2012 |
| Source | Duke University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Primary Aim:
-To explore the feasibility and acceptability of two distinctly different tailored,
home-based diet and exercise interventions (one that relies on a partner-assisted,
team-based approach that emphasizes the mother-daughter bond and one that is delivered to
each independently) vs. standardized materials (attention control). This aim will be
accomplished by assessing overall accrual, and by quantifying retention and adverse events
in each study arm.
The study will be deemed feasible if it achieves the following criteria:
1. Accrual of 67 mother-daughter dyads into the intervention is accomplished within a
1-year period;
2. An attrition rate of less than 20% is achieved; and
3. The frequency of total adverse events is not significantly higher in either of the
intervention arms (as compared to the attention control arm), and there is no more than
one reported serious adverse event that is directly attributable to either of the
interventions.
Detailed process data also will be collected on each intervention, i.e., use and perceived
helpfulness of materials in promoting behavior change, frequency and quality of interaction
between members of the mother-daughter dyad, feedback regarding intervention materials, etc.
Secondary Aim:
-To explore potential effects (and variation) noted among each of the three intervention
arms from baseline to 6 and 12- month follow-up on the following endpoints: BMI, energy
intake and nutrient density of the diet, exercise [min/week and metabolic equivalents
(METs)], self-efficacy to adhere to an energy restricted, plant-based, low saturated fat
diet and increased exercise, blood pressure, health-related quality of life (HRQOL), social
support (in general and as specifically related to healthful dietary and exercise behavior),
and characteristics of the mother-daughter bond (e.g., strength).
Secondary Aim:
-To explore potential mediators and moderators of healthful dietary and exercise behaviors,
such as the strength of the mother-daughter bond, geographic proximity of mothers and
daughters, self-efficacy for lifestyle change, etc.
| Status | Completed |
| Enrollment | 482 |
| Est. completion date | July 2010 |
| Est. primary completion date | March 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: 1. DCIS or Stage I-IIIA Breast Cancer (MOTHERS) 2. Have a biological daughter at least 21 years old (MOTHERS) 3. Body Mass Index between 25 - 40 (MOTHERS) or 25 or above (DAUGHTERS) 4. English Speaking & Writing (MOTHERS & DAUGHTERS) 5. 5th grade or higher educational level (MOTHERS & DAUGHTERS) 6. Willingness to be randomized into the standardized or tailored intervention arms and to undergo baseline and follow-up assessments (MOTHERS & DAUGHTERS) 7. Must be at least 21 years of age (MOTHERS & DAUGHTERS) 8. Must reside within the United States, Puerto Rico or Guam and therefore able to participate in home visits made by Examination Management Services, Inc. (MOTHERS & DAUGHTERS) Exclusion Criteria: 1. Evidence of progressive breast cancer or 2nd primaries (MOTHERS) 2. Pre-existing medical condition(s) that preclude adherence to an unsupervised exercise program or to a diet high in fruits and vegetables, such as the following: untreated stage 3 hypertension; severe orthopedic conditions; scheduled for a hip or knee replacement within 6 months; paralysis; end-stage renal disease; dementia; unstable angina; heart attack, congestive heart failure or pulmonary conditions that have required hospitalization or oxygen within 6 months (MOTHERS & DAUGHTERS) 3. Currently exercising 30+ minutes/day for 5+ days/week (<150 minutes per week) (MOTHERS & DAUGHTERS) 4. Currently enrolled in a weight loss program (MOTHERS & DAUGHTERS) 5. Residing in institutionalized settings, e.g., living in assisted or skilled nursing facilities, and therefore not able to make independent choices about their lifestyle behaviors and participate fully in the intervention (MOTHERS AND DAUGHTERS). 6. Currently pregnant (MOTHERS & DAUGHTERS) 7. A previous diagnosis of breast cancer (DAUGHTERS). |
| Country | Name | City | State |
|---|---|---|---|
| United States | Duke University Medical Center | Durham | North Carolina |
| United States | U.T. M.D. Anderson Cancer Center | Houston | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| Duke University | National Cancer Institute (NCI) |
United States,
Demark-Wahnefried W, Jones LW, Snyder DC, Sloane RJ, Kimmick GG, Hughes DC, Badr HJ, Miller PE, Burke LE, Lipkus IM. Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers w — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Overall Accrual | 12-Months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |